Skip to main content

Table 2 Clinical outcomes and hemodynamics, baseline and change during follow-up

From: Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries

Parameter Baseline Follow-up
  N* Mean ± SD N* Δ during observation (Mean ± SD)
6 MWD, meters 92 298 ± 120 90 30 ± 90
Pulmonary atrial pressure (PAP),mmHg 107 45.5 ± 0.6 51 −2.5 ± 13.4
Pulmonary capillary wedge pressure, mm Hg 98 9.5 ± 4.6 43 −1.0 ± 5.9
Right atrial pressure (RAP), mmHg 96 8.1 ± 5.8 53 −0.43 ± 6.7
Pulmonary vascular resistance (PVR), dyn × sec × cm−5 94 797 ± 416 37 −111 ± 360
Cardiac index, l/min/m2 98 2.2 ± 0.5 49 1.11 ± 3.3
Borg dyspnoea index 81 4.7 ± 2.2 78 −0.5 ± 2.7
FEV1, litres 86 2.0 ± 0.7 71 −0.1 ± 0.3
FEV1/vital capacity 87 71.5 ± 12.3 72 −3.1 ± 10.4
  1. *Sample size may vary due to missing values in the patient records.
  2. FEV1, Forced Expiratory Volume in 1 second; 6-MWD, walking distance in 6 minutes.